Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Other 11Gastrointestinal 10Endocrine 6Breast 6Lymphoid 3Genitourinary 3Thoracic 2Other hematologic neoplasm 2Gynecologic 2Classical hematology 2Plasma cell 1Other solid neoplasm 1Myeloid 1Head & Neck 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 2708Lung Neoplasms 2267Small Cell Lung Carcinoma 452Breast Neoplasms 394Neoplasms 348Colorectal Neoplasms 245Ovarian Neoplasms 208Pancreatic Neoplasms 196Melanoma 196Prostatic Neoplasms 187Adenocarcinoma of Lung 184Neoplasm Metastasis 177Head and Neck Neoplasms 175Mesothelioma, Malignant 152Esophageal Neoplasms 144Carcinoma, Renal Cell 142Stomach Neoplasms 141Colonic Neoplasms 138Urinary Bladder Neoplasms 124Mesothelioma 121Squamous Cell Carcinoma of Head and Neck 115Uterine Cervical Neoplasms 97Sarcoma 86Brain Neoplasms 86Kidney Neoplasms 82Carcinoma, Hepatocellular 71Liver Neoplasms 68Adenocarcinoma, Bronchiolo-Alveolar 68Rectal Neoplasms 64Pleural Effusion, Malignant 64

Interventions

Sulfonylurea Compounds 1Sodium-Glucose Transporter 2 Inhibitors 1Dipeptidyl-Peptidase IV Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Diabetes Mellitus, Type 2 × Thoracic × Clear all
NCT07332156 2026-01-14

Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas

Samsung Medical Center

Completed
21,692 enrolled
Thoracic

Diabetes Mellitus, Type 2, Disease, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

NCT00782366 2011-04-27

PGT

Mayo Clinic

Completed
26 enrolled
BreastGastrointestinalGenitourinaryOtherThoracic

Atrial Fibrillation, Breast Neoplasms, Celiac Disease, Colonic Neoplasms, Diabetes Mellitus, Type 2, Graves Disease, Lung Neoplasms, Myocardial Infarction, Obesity, Osteoarthritis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡